Literature DB >> 28279425

Current Concepts of Cardiac Amyloidosis: Diagnosis, Clinical Management, and the Need for Collaboration.

Alexandra J Ritts1, Robert F Cornell2, Kris Swiger3, Jai Singh3, Stacey Goodman2, Daniel J Lenihan4.   

Abstract

Cardiac amyloidosis is a complex and vexing clinical condition that requires a high degree of suspicion for the diagnosis with a substantial amount of discipline to discern the extent of disease and the best available therapy. There is a complex interplay between multiple organ systems, and the clinical presentation may involve a myriad of confusing clinical symptoms. The diagnosis of cardiac amyloidosis can be confirmed with a combination of physical findings, cardiac biomarkers, noninvasive testing, and, if necessary, myocardial biopsy. Genetic testing is critical to establish the type of amyloidosis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac amyloidosis; Cardiotoxicity; Immunomodulatory drugs; Multiple myeloma; Proteasome inhibitors; TTR

Mesh:

Year:  2017        PMID: 28279425     DOI: 10.1016/j.hfc.2016.12.003

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  9 in total

1.  Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021.

Authors:  Marcus V Simões; Fabio Fernandes; Fabiana G Marcondes-Braga; Philip Scheinberg; Edileide de Barros Correia; Luis Eduardo P Rohde; Fernando Bacal; Silvia Marinho Martins Alves; Sandrigo Mangini; Andréia Biolo; Luis Beck-da-Silva; Roberta Shcolnik Szor; Wilson Marques Junior; Acary Souza Bulle Oliveira; Márcia Waddington Cruz; Bruno Vaz Kerges Bueno; Ludhmila Abrahão Hajjar; Aurora Felice Castro Issa; Felix José Alvarez Ramires; Otavio Rizzi Coelho Filho; André Schmidt; Ibraim Masciarelli Francisco Pinto; Carlos Eduardo Rochitte; Marcelo Luiz Campos Vieira; Cláudio Tinoco Mesquita; Celso Dario Ramos; José Soares-Junior; Minna Moreira Dias Romano; Wilson Mathias Junior; Marcelo Iório Garcia Junior; Marcelo Westerlund Montera; Marcelo Dantas Tavares de Melo; Sandra Marques E Silva; Pedro Manoel Marques Garibaldi; Aristóteles Comte de Alencar Neto; Renato Delascio Lopes; Diane Xavier de Ávila; Denizar Viana; José Francisco Kerr Saraiva; Manoel Fernandes Canesin; Glaucia Maria Moraes de Oliveira; Evandro Tinoco Mesquita
Journal:  Arq Bras Cardiol       Date:  2021-09       Impact factor: 2.000

2.  Cerebral embolism secondary to cardiac amyloidosis: A case report and literature review.

Authors:  Xu-Dong Zhang; Ying-Xian Liu; Xiao-Wei Yan; Li-Gang Fang; Quan Fang; Da-Chun Zhao; Yi-Ning Wang
Journal:  Exp Ther Med       Date:  2017-10-13       Impact factor: 2.447

3.  Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.

Authors:  Panagiota Kyriakou; Dimitrios Mouselimis; Anastasios Tsarouchas; Angelos Rigopoulos; Constantinos Bakogiannis; Michel Noutsias; Vasileios Vassilikos
Journal:  BMC Cardiovasc Disord       Date:  2018-12-04       Impact factor: 2.298

4.  Approach to a patient with cardiac amyloidosis.

Authors:  Christopher Strouse; Alexandros Briasoulis; Rafael Fonseca; Yogesh Jethava
Journal:  J Geriatr Cardiol       Date:  2019-07       Impact factor: 3.327

Review 5.  Advances in the Treatment of Cardiac Amyloidosis.

Authors:  Ariane Vieira Scarlatelli Macedo; Pedro Vellosa Schwartzmann; Breno Moreno de Gusmão; Marcelo Dantas Tavares de Melo; Otávio Rizzi Coelho-Filho
Journal:  Curr Treat Options Oncol       Date:  2020-04-23

6.  Real-World Data and Machine Learning to Predict Cardiac Amyloidosis.

Authors:  Elena García-García; Gracia María González-Romero; Encarna M Martín-Pérez; Enrique de Dios Zapata Cornejo; Gema Escobar-Aguilar; Marlon Félix Cárdenas Bonnet
Journal:  Int J Environ Res Public Health       Date:  2021-01-21       Impact factor: 3.390

7.  Case report: Two sisters with light-chain cardiac amyloidosis, a mere coincidence?

Authors:  Sarah Cappuyns; Matthias Verbesselt; Alexander Van De Bruaene; Jan Bogaert; Lucienne Michaux; Michel Delforge
Journal:  Eur Heart J Case Rep       Date:  2022-02-17

8.  3.0T cardiac magnetic resonance quantification of native T1 and myocardial extracellular volume for the diagnosis of late gadolinium enhancement-negative cardiac amyloidosis.

Authors:  Yumeng Liu; Jingfen Zhu; Meng Chen; Lingjie Wang; Mo Zhu; Zhen Weng; Chunhong Hu
Journal:  Ann Transl Med       Date:  2022-07

9.  Cardiac amyloidosis presenting with recurrent ischaemic strokes.

Authors:  Suleiman Suleiman; John Joseph Coughlan; David Moore
Journal:  BMJ Case Rep       Date:  2020-02-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.